{"id":39284,"date":"2025-11-06T12:35:46","date_gmt":"2025-11-06T20:35:46","guid":{"rendered":"https:\/\/scrum.vc\/ja\/?p=39284"},"modified":"2025-11-13T11:12:59","modified_gmt":"2025-11-13T19:12:59","slug":"scrum-funding-news-20251106","status":"publish","type":"post","link":"https:\/\/scrum.vc\/ja\/2025\/11\/06\/scrum-funding-news-20251106\/","title":{"rendered":"\u4eca\u9031\u306e\u6ce8\u76ee5\u793e\uff1a\u8001\u5316\u8a3a\u65ad\u30ad\u30c3\u30c8 \/ \u6b21\u4e16\u4ee3\u30d0\u30a4\u30aa\u30c7\u30a3\u30d5\u30a7\u30f3\u30b9 \/ \u81ea\u5f8b\u98db\u884c\u30c9\u30ed\u30fc\u30f3\u6d88\u9632\u58eb \/ \u304c\u3093\u6cbb\u7642\u98df\u4e8b\u30d7\u30ed\u30b0\u30e9\u30e0 \/ \u5065\u5eb7\u5bff\u547d\u5ef6\u4f38\u85ac"},"content":{"rendered":"

\u4e00\u9031\u9593\u306e\u8cc7\u91d1\u8abf\u9054\u304a\u3088\u3073M&A\u306e\u30cb\u30e5\u30fc\u30b9\u304b\u3089\u3001\u6ce8\u76ee\u306e\u7c73\u56fd\u30b9\u30bf\u30fc\u30c8\u30a2\u30c3\u30d7\u30925\u793e\u53b3\u9078\u3057\u3066\u7d39\u4ecb\u3057\u307e\u3059\u3002\u30d0\u30c3\u30af\u30ca\u30f3\u30d0\u30fc\u306f\u3053\u3061\u3089\u3002<\/a><\/p>\n

1.\u300c\u8001\u5316\u8a3a\u65ad\u30ad\u30c3\u30c8\u300dGeneration Lab<\/a><\/h1>\n

\"\"<\/p>\n

\u65e5\u672c\u8a9e\u8aad\u307f\uff1a\u30b8\u30a7\u30cd\u30ec\u30fc\u30b7\u30e7\u30f3\u30e9\u30dc
\n\u30ab\u30c6\u30b4\u30ea\uff1aBiotechnology\/\u30d8\u30eb\u30b9\u30b1\u30a2
\n\u30e9\u30a6\u30f3\u30c9\uff1aSeed VC ($11M)
\n\u4e3b\u306a\u6295\u8cc7\u5bb6\uff1aAccel, Aoki Labs, Build Your Legacy Ventures, Markham Valley Ventures, Samsung NEXT, Zone 2 Partners<\/h4>\n

\u4f53\u5185\u5e74\u9f62\u3092\u6e2c\u5b9a\u3059\u308b\u8001\u5316\u8a3a\u65ad\u30ad\u30c3\u30c8\u3002<\/p>\n

\u5728\u5b85\u3067\u306e\u8840\u6db2\u63a1\u53d6\u306b\u3088\u308a\u3001\u751f\u7269\u5b66\u7684\u306a\u4f53\u5185\u5e74\u9f62\u3092\u8a3a\u65ad\u3059\u308b\u30a8\u30d4\u30b8\u30a7\u30cd\u30c6\u30a3\u30c3\u30af\u30c6\u30b9\u30c8\u3092\u958b\u767a\u3059\u308b\u30d8\u30eb\u30b9\u30b1\u30a2\u30c6\u30c3\u30af\u30b9\u30bf\u30fc\u30c8\u30a2\u30c3\u30d7\u3002\u300cSystemAge\u300d\u3068\u547c\u3070\u308c\u3001460\u306e\u30d0\u30a4\u30aa\u30de\u30fc\u30ab\u30fc\u3092\u901a\u3058\u3066\u3001\u8133\u306e\u8a8d\u77e5\u6a5f\u80fd\u3084\u5fc3\u81d3\u3001\u751f\u6b96\u3001\u514d\u75ab\u3001\u4ee3\u8b1d\u306a\u306919\u306e\u81d3\u5668\u3084\u30b7\u30b9\u30c6\u30e0\u306e\u4f53\u5185\u5e74\u9f62\u3092\u6e2c\u5b9a\u53ef\u80fd\u3002\u691c\u67fb\u7d50\u679c\u3092\u3082\u3068\u306b\u3001\u82e5\u8fd4\u308a\u3092\u56f3\u308b\u30d1\u30fc\u30bd\u30ca\u30e9\u30a4\u30ba\u3055\u308c\u305f\u30d7\u30e9\u30f3\u3082\u63d0\u793a\u3057\u3066\u304f\u308c\u308b\u3002\u4fa1\u683c\u306f499\u30c9\u30eb\u3002\u767a\u58f2\u304b\u3089\u308f\u305a\u304b\u4e00\u5e74\u3067\u3001275\u4ee5\u4e0a\u306e\u30af\u30ea\u30cb\u30c3\u30af\u3068\u5951\u7d04\u3092\u4ea4\u308f\u3057\u3066\u3044\u308b\u3002<\/p>\n

2023\u5e74\u5275\u696d\u3001\u672c\u793e\u306f\u30b5\u30f3\u30d5\u30e9\u30f3\u30b7\u30b9\u30b3\u3002Accel\u7b49\u304b\u3089\u4eca\u56de\u8abf\u9054\u3057\u305f$11M\u306f\u3001\u30b5\u30fc\u30d3\u30b9\u306e\u62e1\u5927\u306b\u6d3b\u7528\u3059\u308b\u4e88\u5b9a\u3002<\/p>\n

2.\u300c\u6b21\u4e16\u4ee3\u30d0\u30a4\u30aa\u30c7\u30a3\u30d5\u30a7\u30f3\u30b9\u300dValthos<\/a><\/h1>\n

\"\"<\/p>\n

\u65e5\u672c\u8a9e\u8aad\u307f\uff1a\u30d0\u30eb\u30c8\u30b9
\n\u30ab\u30c6\u30b4\u30ea\uff1aBiotechnology\/\u9632\u885b
\n\u30e9\u30a6\u30f3\u30c9\uff1aSeries A ($30M)
\n\u4e3b\u306a\u6295\u8cc7\u5bb6\uff1aFounders Fund, Lux Capital, OpenAI Startup Fund<\/h4>\n

AI\u3092\u6d3b\u7528\u3057\u305f\u6b21\u4e16\u4ee3\u30d0\u30a4\u30aa\u30c7\u30a3\u30d5\u30a7\u30f3\u30b9\u3002<\/p>\n

AI\u3092\u6d3b\u7528\u3057\u3001\u751f\u7269\u5175\u5668\u306b\u3088\u308b\u653b\u6483\u3084\u8105\u5a01\u3092\u9632\u5fa1\u3059\u308b\u305f\u3081\u306e\u6b21\u4e16\u4ee3\u30d0\u30a4\u30aa\u30c7\u30a3\u30d5\u30a7\u30f3\u30b9\uff08\u30bb\u30ad\u30e5\u30ea\u30c6\u30a3\uff09\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3092\u958b\u767a\u3059\u308b\u9632\u885b\u30c6\u30c3\u30af\u30b9\u30bf\u30fc\u30c8\u30a2\u30c3\u30d7\u3002\u75c5\u539f\u4f53\u306e\u51fa\u73fe\u3092\u306f\u3058\u3081\u3068\u3059\u308b\u751f\u7269\u5b66\u7684\u8105\u5a01\u3092\u5373\u5ea7\u306b\u691c\u77e5\u3057\u3001\u533b\u7642\u5bfe\u7b56\u3092\u30ea\u30a2\u30eb\u30bf\u30a4\u30e0\u306b\u8a2d\u8a08\u3059\u308b\u3053\u3068\u3067\u8fc5\u901f\u304b\u3064\u6b63\u78ba\u306a\u5bfe\u5fdc\u304c\u53ef\u80fd\u3068\u3044\u3046\u3002Palantir\u3084DeepMind\u306e\u51fa\u8eab\u30e1\u30f3\u30d0\u30fc\u304c\u5275\u696d\u8005\u306b\u540d\u3092\u9023\u306d\u3001OpenAI\u3082\u51fa\u8cc7\u3059\u308b\u6ce8\u76ee\u30b9\u30bf\u30fc\u30c8\u30a2\u30c3\u30d7\u3002<\/p>\n

2024\u5e74\u5275\u696d\u3001\u672c\u793e\u306f\u30cb\u30e5\u30fc\u30e8\u30fc\u30af\u3002Founders Fund\u7b49\u304b\u3089\u4eca\u56de\u8abf\u9054\u3057\u305f$30M\u306f\u3001\u5f15\u304d\u7d9a\u304d\u958b\u767a\u8cbb\u7528\u306b\u6d3b\u7528\u3059\u308b\u4e88\u5b9a\u3002<\/p>\n

3.\u300c\u81ea\u5f8b\u98db\u884c\u30c9\u30ed\u30fc\u30f3\u6d88\u9632\u58eb\u300dSeneca<\/a><\/h1>\n

\"\"<\/p>\n

\u65e5\u672c\u8a9e\u8aad\u307f\uff1a\u30bb\u30cd\u30ab
\n\u30ab\u30c6\u30b4\u30ea\uff1aHW\/\u30c9\u30ed\u30fc\u30f3
\n\u30e9\u30a6\u30f3\u30c9\uff1aSeries A ($60M)
\n\u4e3b\u306a\u6295\u8cc7\u5bb6\uff1aCaffeinated Capital, Convective Capital, Advance Venture Partners, Bullpen Capital, DCVC, First Round Capital, Fritz Lanman, Good Friends, MHS Capital, NextView Ventures, Offline Ventures, Roar Venture, Slow Ventures, Stepstone Group, Transition<\/h4>\n

\u81ea\u5f8b\u98db\u884c\u3059\u308b\u6d88\u706b\u30c9\u30ed\u30fc\u30f3\u306e\u958b\u767a\u3002<\/p>\n

\u30ed\u30dc\u30c3\u30c8\u5de5\u5b66\u304a\u3088\u3073AI\u3092\u99c6\u4f7f\u3057\u3001\u81ea\u5f8b\u98db\u884c\u3057\u306a\u304c\u3089\u6d88\u706b\u6d3b\u52d5\u3092\u884c\u3046\u30c9\u30ed\u30fc\u30f3\u6d88\u9632\u58eb\u3092\u958b\u767a\u3059\u308b\u30b9\u30bf\u30fc\u30c8\u30a2\u30c3\u30d7\u3002\u706b\u707d\u3092\u691c\u77e5\u3059\u308b\u3068\u73fe\u5834\u307e\u3067\u6025\u884c\u3057\u3001\u9ad8\u3044\u6c34\u5727\u3067\u6b63\u78ba\u306b\u6a19\u7684\u3092\u6d88\u706b\u3059\u308b\u3068\u3044\u3046\u3002\u307e\u305f\u3001\u4e0a\u7a7a\u304b\u3089\u306e\u6620\u50cf\u3067\u706b\u707d\u73fe\u5834\u306e\u72b6\u6cc1\u3082\u5b89\u5168\u306b\u78ba\u8a8d\u3067\u304d\u308b\u3002\u30a2\u30af\u30bb\u30b9\u304c\u56f0\u96e3\u306a\u5730\u5f62\u306b\u304a\u3051\u308b\u521d\u671f\u706b\u707d\u306e\u78ba\u8a8d\u3084\u93ae\u5727\u304b\u3089\u3001\u5927\u898f\u6a21\u706b\u707d\u767a\u751f\u6642\u306e\u6d88\u706b\u6d3b\u52d5\u307e\u3067\u3001\u69d8\u3005\u306a\u72b6\u6cc1\u306b\u5bfe\u5fdc\u53ef\u80fd\u30022026\u5e74\u306e\u73fe\u5834\u5c0e\u5165\u306b\u5411\u3051\u3066\u73fe\u5728\u958b\u767a\u304c\u9032\u3081\u3089\u308c\u3066\u3044\u308b\u3002<\/p>\n

2024\u5e74\u5275\u696d\u3001\u672c\u793e\u306f\u30b5\u30f3\u30d5\u30e9\u30f3\u30b7\u30b9\u30b3\u3002Caffeinated Capital\u7b49\u304b\u3089\u4eca\u56de\u8abf\u9054\u3057\u305f$60M\u306f\u3001\u65b0\u6a5f\u80fd\u306e\u958b\u767a\u304a\u3088\u3073\u751f\u7523\u80fd\u529b\u62e1\u5927\u306b\u6d3b\u7528\u3059\u308b\u4e88\u5b9a\u3002<\/p>\n

4.\u300c\u304c\u3093\u6cbb\u7642\u98df\u4e8b\u30d7\u30ed\u30b0\u30e9\u30e0\u300dFaeth Therapeutics<\/a><\/h1>\n

\"\"<\/p>\n

\u65e5\u672c\u8a9e\u8aad\u307f\uff1a\u30d5\u30a7\u30a4\u30b9\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9
\n\u30ab\u30c6\u30b4\u30ea\uff1aBiotechnology\/\u30d8\u30eb\u30b9\u30b1\u30a2
\n\u30e9\u30a6\u30f3\u30c9\uff1aSeries B ($25M)
\n\u4e3b\u306a\u6295\u8cc7\u5bb6\uff1aS2G Investments, Avicella Capital, B Capital, Cantos, Digitalis Ventures, Future Ventures, KdT Ventures, Khosla Ventures, THO SeedFund<\/h4>\n

\u304c\u3093\u6cbb\u7642\u306e\u305f\u3081\u306e\u98df\u4e8b\u30b3\u30f3\u30c8\u30ed\u30fc\u30eb\u30d7\u30ed\u30b0\u30e9\u30e0\u3002<\/p>\n

\u304c\u3093\u60a3\u8005\u304c\u6442\u53d6\u3059\u308b\u98df\u4e8b\uff08\u6804\u990a\u6210\u5206\uff09\u3092\u30b3\u30f3\u30c8\u30ed\u30fc\u30eb\u3059\u308b\u3053\u3068\u3067\u3001\u304c\u3093\u7d30\u80de\u306e\u6a5f\u80fd\u3092\u4f4e\u4e0b\u3055\u305b\u308b\u65b0\u305f\u306a\u304c\u3093\u6cbb\u7642\u6cd5\u3092\u958b\u767a\u3059\u308b\u30d0\u30a4\u30aa\u30c6\u30c3\u30af\u30b9\u30bf\u30fc\u30c8\u30a2\u30c3\u30d7\u3002\u304c\u3093\u306e\u7a2e\u985e\u306b\u5fdc\u3058\u3066\u3001\u30d1\u30fc\u30bd\u30ca\u30e9\u30a4\u30ba\u3055\u308c\u305f\u98df\u4e8b\u304c\u5c4a\u3051\u3089\u308c\u308b\u4ed5\u7d44\u307f\u3002\u307e\u305f\u3001\u30a2\u30d7\u30ea\u3092\u4ecb\u3057\u3066\u5c02\u5c5e\u306e\u6804\u990a\u58eb\u306b\u3088\u308b\u30aa\u30f3\u30c7\u30de\u30f3\u30c9\u30b5\u30dd\u30fc\u30c8\u3082\u63d0\u4f9b\u3057\u3001\u304c\u3093\u7d30\u80de\u306e\u4ee3\u8b1d\u3092\u963b\u5bb3\u3059\u308b\u3053\u3068\u306b\u3088\u308a\u6cbb\u7642\u52b9\u679c\u3092\u9ad8\u3081\u308b\u3068\u3044\u3046\u3002\u73fe\u5728\u3001\u5b50\u5bae\u5185\u819c\u304c\u3093\u306e\u6cbb\u7642\u3092\u91cd\u70b9\u7684\u306b\u9032\u3081\u3066\u3044\u308b\u3002<\/p>\n

2019\u5e74\u5275\u696d\u3001\u672c\u793e\u306f\u30c6\u30ad\u30b5\u30b9\u5dde\u30aa\u30fc\u30b9\u30c6\u30a3\u30f3\u3002S2G Investments\u7b49\u304b\u3089\u4eca\u56de\u8abf\u9054\u3057\u305f$25M\u306f\u3001\u5f15\u304d\u7d9a\u304d\u958b\u767a\u8cbb\u7528\u306b\u6d3b\u7528\u3059\u308b\u4e88\u5b9a\u3002<\/p>\n

5.\u300c\u5065\u5eb7\u5bff\u547d\u5ef6\u4f38\u85ac\u300dNewLimit<\/a><\/h1>\n

\"\"<\/p>\n

\u65e5\u672c\u8a9e\u8aad\u307f\uff1a\u30cb\u30e5\u30fc\u30ea\u30df\u30c3\u30c8
\n\u30ab\u30c6\u30b4\u30ea\uff1aBiotechnology\/DNA
\n\u30e9\u30a6\u30f3\u30c9\uff1aSeries B-II ($45M)
\n\u4e3b\u306a\u6295\u8cc7\u5bb6\uff1aAbstract, Boost VC, DUMAC, Dimension, Eli Lilly and Company, Human Capital, Kleiner Perkins, Section 32<\/h4>\n

\u5065\u5eb7\u5bff\u547d\u3092\u5ef6\u3070\u3059\u65b0\u85ac\u306e\u958b\u767a\u3002<\/p>\n

\u30a8\u30d4\u30b2\u30ce\u30e0\u3092\u518d\u30d7\u30ed\u30b0\u30e9\u30e0\u5316\u3059\u308b\u3053\u3068\u3067\u3001\u8001\u5316\u7d30\u80de\u306e\u6a5f\u80fd\u3092\u56de\u5fa9\u3055\u305b\u308b\u533b\u85ac\u54c1\u3092\u958b\u767a\u3059\u308b\u30d0\u30a4\u30aa\u30c6\u30c3\u30af\u30b9\u30bf\u30fc\u30c8\u30a2\u30c3\u30d7\u3002\u4eba\u9593\u306e\u7d30\u80de\u5185\u306e\u7279\u5b9a\u30bf\u30f3\u30d1\u30af\u8cea\u306b\u7126\u70b9\u3092\u5f53\u3066\u3001\u518d\u30d7\u30ed\u30b0\u30e9\u30e0\u5316\u3059\u308b\u3053\u3068\u3067\u8001\u5316\u306e\u5f71\u97ff\u3092\u6291\u5236\u3059\u308b\u3053\u3068\u3092\u76ee\u6307\u3059\u3068\u3044\u3046\u3002\u73fe\u5728\u3001\u809d\u7d30\u80de\u3092\u518d\u30d7\u30ed\u30b0\u30e9\u30e0\u5316\u3059\u308b\u65b0\u85ac\u306e\u958b\u767a\u3092\u9032\u3081\u3066\u3044\u308b\u3002Coinbase CEO\u306eBrian Armstrong\u304c\u5275\u696d\u3057\u305f\u3053\u3068\u3067\u3082\u6ce8\u76ee\u3055\u308c\u3066\u3044\u308b\u3002\u4eca\u56de\u306e\u8cc7\u91d1\u8abf\u9054\u306b\u3088\u308b\u30d0\u30ea\u30e5\u30a8\u30fc\u30b7\u30e7\u30f3\u306f16\u5104\u30c9\u30eb\u3068\u3001\u30e6\u30cb\u30b3\u30fc\u30f3\u4f01\u696d\u306e\u4ef2\u9593\u5165\u308a\u3002<\/p>\n

2021\u5e74\u5275\u696d\u3001\u672c\u793e\u306f\u30ab\u30ea\u30d5\u30a9\u30eb\u30cb\u30a2\u5dde\u30b5\u30a6\u30b9\u30b5\u30f3\u30d5\u30e9\u30f3\u30b7\u30b9\u30b3\u3002Abstract\u7b49\u304b\u3089\u4eca\u56de\u8abf\u9054\u3057\u305f$45M\u306f\u3001\u5f15\u304d\u7d9a\u304d\u958b\u767a\u8cbb\u7528\u306b\u6d3b\u7528\u3059\u308b\u4e88\u5b9a\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"\u4e00\u9031\u9593\u306e\u8cc7\u91d1\u8abf\u9054\u304a\u3088\u3073M&A\u306e\u30cb\u30e5\u30fc\u30b9\u304b\u3089\u3001\u6ce8\u76ee\u306e\u7c73\u56fd\u30b9\u30bf\u30fc\u30c8\u30a2\u30c3\u30d7\u30925\u793e\u53b3\u9078\u3057\u3066\u7d39\u4ecb\u3057\u307e\u3059\u3002\u30d0\u30c3\u30af\u30ca\u30f3\u30d0\u30fc\u306f\u3053\u3061\u3089\u3002 1.\u300c\u8001\u5316\u8a3a\u65ad\u30ad\u30c3\u30c8\u300dGeneration Lab \u65e5\u672c\u8a9e\u8aad\u307f\uff1a\u30b8\u30a7\u30cd\u30ec\u30fc\u30b7\u30e7\u30f3\u30e9\u30dc \u30ab\u30c6\u30b4\u30ea\uff1aBiotechnology\/\u30d8\u30eb\u30b9\u30b1\u30a2 \u30e9\u30a6\u30f3\u30c9\uff1aSeed VC ($11M) \u4e3b\u306a\u6295\u8cc7\u5bb6\uff1aAccel, Aoki Labs, Build Your Legacy Ventures, Markham Valley Ventures, Samsung NEXT, Zone 2 Partners \u4f53\u5185\u5e74\u9f62\u3092\u6e2c\u5b9a\u3059\u308b\u8001\u5316\u8a3a\u65ad\u30ad\u30c3\u30c8\u3002 \u5728\u5b85\u3067\u306e\u8840\u6db2\u63a1\u53d6\u306b\u3088\u308a\u3001\u751f\u7269\u5b66\u7684\u306a\u4f53\u5185\u5e74\u9f62\u3092\u8a3a\u65ad\u3059\u308b\u30a8\u30d4\u30b8\u30a7\u30cd\u30c6\u30a3\u30c3\u30af\u30c6\u30b9\u30c8\u3092\u958b\u767a\u3059\u308b\u30d8\u30eb\u30b9\u30b1\u30a2\u30c6\u30c3\u30af\u30b9\u30bf\u30fc\u30c8\u30a2\u30c3\u30d7\u3002\u300cSystemAge\u300d\u3068\u547c\u3070\u308c\u3001460\u306e\u30d0\u30a4\u30aa\u30de\u30fc\u30ab\u30fc\u3092\u901a\u3058\u3066\u3001\u8133\u306e\u8a8d\u77e5\u6a5f\u80fd\u3084\u5fc3\u81d3\u3001\u751f\u6b96\u3001\u514d\u75ab\u3001\u4ee3\u8b1d\u306a\u306919\u306e\u81d3\u5668\u3084\u30b7\u30b9\u30c6\u30e0\u306e\u4f53\u5185\u5e74\u9f62\u3092\u6e2c\u5b9a\u53ef\u80fd\u3002\u691c\u67fb\u7d50\u679c\u3092\u3082\u3068\u306b\u3001\u82e5\u8fd4\u308a\u3092\u56f3\u308b\u30d1\u30fc\u30bd\u30ca\u30e9\u30a4\u30ba\u3055\u308c\u305f\u30d7\u30e9\u30f3\u3082\u63d0\u793a\u3057\u3066\u304f\u308c\u308b\u3002\u4fa1\u683c\u306f499\u30c9\u30eb\u3002\u767a\u58f2\u304b\u3089\u308f\u305a\u304b\u4e00\u5e74\u3067\u3001275\u4ee5\u4e0a\u306e\u30af\u30ea\u30cb\u30c3\u30af\u3068\u5951\u7d04\u3092\u4ea4\u308f\u3057\u3066\u3044\u308b\u3002 2023\u5e74\u5275\u696d\u3001\u672c\u793e\u306f\u30b5\u30f3\u30d5\u30e9\u30f3\u30b7\u30b9\u30b3\u3002Accel\u7b49\u304b\u3089\u4eca\u56de\u8abf\u9054\u3057\u305f$11M\u306f\u3001\u30b5\u30fc\u30d3\u30b9\u306e\u62e1\u5927\u306b\u6d3b\u7528\u3059\u308b\u4e88\u5b9a\u3002 2.\u300c\u6b21\u4e16\u4ee3\u30d0\u30a4\u30aa\u30c7\u30a3\u30d5\u30a7\u30f3\u30b9\u300dValthos \u65e5\u672c\u8a9e\u8aad\u307f\uff1a\u30d0\u30eb\u30c8\u30b9 \u30ab\u30c6\u30b4\u30ea\uff1aBiotechnology\/\u9632\u885b \u30e9\u30a6\u30f3\u30c9\uff1aSeries A ($30M) \u4e3b\u306a\u6295\u8cc7\u5bb6\uff1aFounders Fund, Lux Capital, OpenAI Startup Fund AI\u3092\u6d3b\u7528\u3057\u305f\u6b21\u4e16\u4ee3\u30d0\u30a4\u30aa\u30c7\u30a3\u30d5\u30a7\u30f3\u30b9\u3002 AI\u3092\u6d3b\u7528\u3057\u3001\u751f\u7269\u5175\u5668\u306b\u3088\u308b\u653b\u6483\u3084\u8105\u5a01\u3092\u9632\u5fa1\u3059\u308b\u305f\u3081\u306e\u6b21\u4e16\u4ee3\u30d0\u30a4\u30aa\u30c7\u30a3\u30d5\u30a7\u30f3\u30b9\uff08\u30bb\u30ad\u30e5\u30ea\u30c6\u30a3\uff09\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3092\u958b\u767a\u3059\u308b\u9632\u885b\u30c6\u30c3\u30af\u30b9\u30bf\u30fc\u30c8\u30a2\u30c3\u30d7\u3002\u75c5\u539f\u4f53\u306e\u51fa\u73fe\u3092\u306f\u3058\u3081\u3068\u3059\u308b\u751f\u7269\u5b66\u7684\u8105\u5a01\u3092\u5373\u5ea7\u306b\u691c\u77e5\u3057\u3001\u533b\u7642\u5bfe\u7b56\u3092\u30ea\u30a2\u30eb\u30bf\u30a4\u30e0\u306b\u8a2d\u8a08\u3059\u308b\u3053\u3068\u3067\u8fc5\u901f\u304b\u3064\u6b63\u78ba\u306a\u5bfe\u5fdc\u304c\u53ef\u80fd\u3068\u3044\u3046\u3002Palantir\u3084DeepMind\u306e\u51fa\u8eab\u30e1\u30f3\u30d0\u30fc\u304c\u5275\u696d\u8005\u306b\u540d\u3092\u9023\u306d\u3001OpenAI\u3082\u51fa\u8cc7\u3059\u308b\u6ce8\u76ee\u30b9\u30bf\u30fc\u30c8\u30a2\u30c3\u30d7\u3002 2024\u5e74\u5275\u696d\u3001\u672c\u793e\u306f\u30cb\u30e5\u30fc\u30e8\u30fc\u30af\u3002Founders Fund\u7b49\u304b\u3089\u4eca\u56de\u8abf\u9054\u3057\u305f$30M\u306f\u3001\u5f15\u304d\u7d9a\u304d\u958b\u767a\u8cbb\u7528\u306b\u6d3b\u7528\u3059\u308b\u4e88\u5b9a\u3002 3.\u300c\u81ea\u5f8b\u98db\u884c\u30c9\u30ed\u30fc\u30f3\u6d88\u9632\u58eb\u300dSeneca \u65e5\u672c\u8a9e\u8aad\u307f\uff1a\u30bb\u30cd\u30ab \u30ab\u30c6\u30b4\u30ea\uff1aHW\/\u30c9\u30ed\u30fc\u30f3 \u30e9\u30a6\u30f3\u30c9\uff1aSeries A ($60M) \u4e3b\u306a\u6295\u8cc7\u5bb6\uff1aCaffeinated Capital, Convective Capital, Advance Venture Partners, Bullpen Capital, DCVC, First Round Capital, Fritz Lanman, Good Friends, MHS Capital, NextView Ventures, Offline Ventures, Roar Venture, Slow Ventures, Stepstone Group, Transition \u81ea\u5f8b\u98db\u884c\u3059\u308b\u6d88\u706b\u30c9\u30ed\u30fc\u30f3\u306e\u958b\u767a\u3002 \u30ed\u30dc\u30c3\u30c8\u5de5\u5b66\u304a\u3088\u3073AI\u3092\u99c6\u4f7f\u3057\u3001\u81ea\u5f8b\u98db\u884c\u3057\u306a\u304c\u3089\u6d88\u706b\u6d3b\u52d5\u3092\u884c\u3046\u30c9\u30ed\u30fc\u30f3\u6d88\u9632\u58eb\u3092\u958b\u767a\u3059\u308b\u30b9\u30bf\u30fc\u30c8\u30a2\u30c3\u30d7\u3002\u706b\u707d\u3092\u691c\u77e5\u3059\u308b\u3068\u73fe\u5834\u307e\u3067\u6025\u884c\u3057\u3001\u9ad8\u3044\u6c34\u5727\u3067\u6b63\u78ba\u306b\u6a19\u7684\u3092\u6d88\u706b\u3059\u308b\u3068\u3044\u3046\u3002\u307e\u305f\u3001\u4e0a\u7a7a\u304b\u3089\u306e\u6620\u50cf\u3067\u706b\u707d\u73fe\u5834\u306e\u72b6\u6cc1\u3082\u5b89\u5168\u306b\u78ba\u8a8d\u3067\u304d\u308b\u3002\u30a2\u30af\u30bb\u30b9\u304c\u56f0\u96e3\u306a\u5730\u5f62\u306b\u304a\u3051\u308b\u521d\u671f\u706b\u707d\u306e\u78ba\u8a8d\u3084\u93ae\u5727\u304b\u3089\u3001\u5927\u898f\u6a21\u706b\u707d\u767a\u751f\u6642\u306e\u6d88\u706b\u6d3b\u52d5\u307e\u3067\u3001\u69d8\u3005\u306a\u72b6\u6cc1\u306b\u5bfe\u5fdc\u53ef\u80fd\u30022026\u5e74\u306e\u73fe\u5834\u5c0e\u5165\u306b\u5411\u3051\u3066\u73fe\u5728\u958b\u767a\u304c\u9032\u3081\u3089\u308c\u3066\u3044\u308b\u3002 2024\u5e74\u5275\u696d\u3001\u672c\u793e\u306f\u30b5\u30f3\u30d5\u30e9\u30f3\u30b7\u30b9\u30b3\u3002Caffeinated Capital\u7b49\u304b\u3089\u4eca\u56de\u8abf\u9054\u3057\u305f$60M\u306f\u3001\u65b0\u6a5f\u80fd\u306e\u958b\u767a\u304a\u3088\u3073\u751f\u7523\u80fd\u529b\u62e1\u5927\u306b\u6d3b\u7528\u3059\u308b\u4e88\u5b9a\u3002 4.\u300c\u304c\u3093\u6cbb\u7642\u98df\u4e8b\u30d7\u30ed\u30b0\u30e9\u30e0\u300dFaeth Therapeutics \u65e5\u672c\u8a9e\u8aad\u307f\uff1a\u30d5\u30a7\u30a4\u30b9\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9 \u30ab\u30c6\u30b4\u30ea\uff1aBiotechnology\/\u30d8\u30eb\u30b9\u30b1\u30a2 \u30e9\u30a6\u30f3\u30c9\uff1aSeries B ($25M) \u4e3b\u306a\u6295\u8cc7\u5bb6\uff1aS2G Investments, Avicella Capital, B Capital, Cantos, Digitalis Ventures, Future Ventures, KdT Ventures, Khosla Ventures, THO SeedFund \u304c\u3093\u6cbb\u7642\u306e\u305f\u3081\u306e\u98df\u4e8b\u30b3\u30f3\u30c8\u30ed\u30fc\u30eb\u30d7\u30ed\u30b0\u30e9\u30e0\u3002 \u304c\u3093\u60a3\u8005\u304c\u6442\u53d6\u3059\u308b\u98df\u4e8b\uff08\u6804\u990a\u6210\u5206\uff09\u3092\u30b3\u30f3\u30c8\u30ed\u30fc\u30eb\u3059\u308b\u3053\u3068\u3067\u3001\u304c\u3093\u7d30\u80de\u306e\u6a5f\u80fd\u3092\u4f4e\u4e0b\u3055\u305b\u308b\u65b0\u305f\u306a\u304c\u3093\u6cbb\u7642\u6cd5\u3092\u958b\u767a\u3059\u308b\u30d0\u30a4\u30aa\u30c6\u30c3\u30af\u30b9\u30bf\u30fc\u30c8\u30a2\u30c3\u30d7\u3002\u304c\u3093\u306e\u7a2e\u985e\u306b\u5fdc\u3058\u3066\u3001\u30d1\u30fc\u30bd\u30ca\u30e9\u30a4\u30ba\u3055\u308c\u305f\u98df\u4e8b\u304c\u5c4a\u3051\u3089\u308c\u308b\u4ed5\u7d44\u307f\u3002\u307e\u305f\u3001\u30a2\u30d7\u30ea\u3092\u4ecb\u3057\u3066\u5c02\u5c5e\u306e\u6804\u990a\u58eb\u306b\u3088\u308b\u30aa\u30f3\u30c7\u30de\u30f3\u30c9\u30b5\u30dd\u30fc\u30c8\u3082\u63d0\u4f9b\u3057\u3001\u304c\u3093\u7d30\u80de\u306e\u4ee3\u8b1d\u3092\u963b\u5bb3\u3059\u308b\u3053\u3068\u306b\u3088\u308a\u6cbb\u7642\u52b9\u679c\u3092\u9ad8\u3081\u308b\u3068\u3044\u3046\u3002\u73fe\u5728\u3001\u5b50\u5bae\u5185\u819c\u304c\u3093\u306e\u6cbb\u7642\u3092\u91cd\u70b9\u7684\u306b\u9032\u3081\u3066\u3044\u308b\u3002 2019\u5e74\u5275\u696d\u3001\u672c\u793e\u306f\u30c6\u30ad\u30b5\u30b9\u5dde\u30aa\u30fc\u30b9\u30c6\u30a3\u30f3\u3002S2G Investments\u7b49\u304b\u3089\u4eca\u56de\u8abf\u9054\u3057\u305f$25M\u306f\u3001\u5f15\u304d\u7d9a\u304d\u958b\u767a\u8cbb\u7528\u306b\u6d3b\u7528\u3059\u308b\u4e88\u5b9a\u3002 5.\u300c\u5065\u5eb7\u5bff\u547d\u5ef6\u4f38\u85ac\u300dNewLimit \u65e5\u672c\u8a9e\u8aad\u307f\uff1a\u30cb\u30e5\u30fc\u30ea\u30df\u30c3\u30c8 \u30ab\u30c6\u30b4\u30ea\uff1aBiotechnology\/DNA \u30e9\u30a6\u30f3\u30c9\uff1aSeries B-II ($45M) \u4e3b\u306a\u6295\u8cc7\u5bb6\uff1aAbstract, Boost VC, DUMAC, Dimension, Eli Lilly and Company, Human Capital, Kleiner Perkins, Section 32 \u5065\u5eb7\u5bff\u547d\u3092\u5ef6\u3070\u3059\u65b0\u85ac\u306e\u958b\u767a\u3002 \u30a8\u30d4\u30b2\u30ce\u30e0\u3092\u518d\u30d7\u30ed\u30b0\u30e9\u30e0\u5316\u3059\u308b\u3053\u3068\u3067\u3001\u8001\u5316\u7d30\u80de\u306e\u6a5f\u80fd\u3092\u56de\u5fa9\u3055\u305b\u308b\u533b\u85ac\u54c1\u3092\u958b\u767a\u3059\u308b\u30d0\u30a4\u30aa\u30c6\u30c3\u30af\u30b9\u30bf\u30fc\u30c8\u30a2\u30c3\u30d7\u3002\u4eba\u9593\u306e\u7d30\u80de\u5185\u306e\u7279\u5b9a\u30bf\u30f3\u30d1\u30af\u8cea\u306b\u7126\u70b9\u3092\u5f53\u3066\u3001\u518d\u30d7\u30ed\u30b0\u30e9\u30e0\u5316\u3059\u308b\u3053\u3068\u3067\u8001\u5316\u306e\u5f71\u97ff\u3092\u6291\u5236\u3059\u308b\u3053\u3068\u3092\u76ee\u6307\u3059\u3068\u3044\u3046\u3002\u73fe\u5728\u3001\u809d\u7d30\u80de\u3092\u518d\u30d7\u30ed\u30b0\u30e9\u30e0\u5316\u3059\u308b\u65b0\u85ac\u306e\u958b\u767a\u3092\u9032\u3081\u3066\u3044\u308b\u3002Coinbase CEO\u306eBrian Armstrong\u304c\u5275\u696d\u3057\u305f\u3053\u3068\u3067\u3082\u6ce8\u76ee\u3055\u308c\u3066\u3044\u308b\u3002\u4eca\u56de\u306e\u8cc7\u91d1\u8abf\u9054\u306b\u3088\u308b\u30d0\u30ea\u30e5\u30a8\u30fc\u30b7\u30e7\u30f3\u306f16\u5104\u30c9\u30eb\u3068\u3001\u30e6\u30cb\u30b3\u30fc\u30f3\u4f01\u696d\u306e\u4ef2\u9593\u5165\u308a\u3002 2021\u5e74\u5275\u696d\u3001\u672c\u793e\u306f\u30ab\u30ea\u30d5\u30a9\u30eb\u30cb\u30a2\u5dde\u30b5\u30a6\u30b9\u30b5\u30f3\u30d5\u30e9\u30f3\u30b7\u30b9\u30b3\u3002Abstract\u7b49\u304b\u3089\u4eca\u56de\u8abf\u9054\u3057\u305f$45M\u306f\u3001\u5f15\u304d\u7d9a\u304d\u958b\u767a\u8cbb\u7528\u306b\u6d3b\u7528\u3059\u308b\u4e88\u5b9a\u3002","protected":false},"author":13,"featured_media":39294,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[222],"tags":[],"class_list":["post-39284","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-funding-news"],"acf":[],"_links":{"self":[{"href":"https:\/\/scrum.vc\/ja\/wp-json\/wp\/v2\/posts\/39284"}],"collection":[{"href":"https:\/\/scrum.vc\/ja\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/scrum.vc\/ja\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/scrum.vc\/ja\/wp-json\/wp\/v2\/users\/13"}],"replies":[{"embeddable":true,"href":"https:\/\/scrum.vc\/ja\/wp-json\/wp\/v2\/comments?post=39284"}],"version-history":[{"count":7,"href":"https:\/\/scrum.vc\/ja\/wp-json\/wp\/v2\/posts\/39284\/revisions"}],"predecessor-version":[{"id":39297,"href":"https:\/\/scrum.vc\/ja\/wp-json\/wp\/v2\/posts\/39284\/revisions\/39297"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/scrum.vc\/ja\/wp-json\/wp\/v2\/media\/39294"}],"wp:attachment":[{"href":"https:\/\/scrum.vc\/ja\/wp-json\/wp\/v2\/media?parent=39284"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/scrum.vc\/ja\/wp-json\/wp\/v2\/categories?post=39284"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/scrum.vc\/ja\/wp-json\/wp\/v2\/tags?post=39284"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}